AIM
DGX icon

Achmea Investment Management’s Quest Diagnostics DGX Stock Holding History

Achmea Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.4M Sell
124,786
-12,333
-9% -$2.42M 0.66% 43
2026
Q1 		$26.9M Sell
137,119
-869
-0.6% -$169K 0.71% 41
2025
Q4 		$23.9M Sell
137,988
-6,221
-4% -$1.13M 0.61% 45
2025
Q3 		$27.5M Buy
144,209
+7,180
+5% +$1.27M 0.34% 80
2025
Q2 		$24.6M Buy
137,029
+563
+0.4% +$97.8K 0.32% 83
2025
Q1 		$23.1M Sell
136,466
-1,680
-1% -$276K 0.34% 80
2024
Q4 		$20.8M Buy
138,146
+73,871
+115% +$11.5M 0.34% 69
2024
Q3 		$9.98M Buy
64,275
+55,731
+652% +$8.32M 0.16% 155
2024
Q2 		$1.17M Buy
8,544
+1,310
+18% +$179K 0.02% 342
2024
Q1 		$963K Sell
7,234
-27,293
-79% -$3.54M 0.02% 367
2023
Q4 		$4.76M Sell
34,527
-1,067
-3% -$140K 0.1% 224
2023
Q3 		$4.34M Sell
35,594
-22,449
-39% -$2.99M 0.09% 224
2023
Q2 		$8.16M Buy
58,043
+3,115
+6% +$429K 0.17% 141
2023
Q1 		$7.77M Buy
54,928
+4,098
+8% +$586K 0.23% 119
2022
Q4 		$7.45M Buy
50,830
+1,348
+3% +$194K 0.25% 108
2022
Q3 		$6.07M Sell
49,482
-7,433
-13% -$979K 0.21% 119
2022
Q2 		$7.57M Sell
56,915
-3,035
-5% -$414K 0.24% 102
2022
Q1 		$8.21M Buy
+59,950
New +$8.36M 0.21% 114
2021
Q4 		– Sell
-67,694
Closed -$9.84M – 357
2021
Q3 		$9.84M Buy
67,694
+1,523
+2% +$223K 0.3% 90
2021
Q2 		$8.73M Buy
66,171
+676
+1% +$88.5K 0.3% 86
2021
Q1 		$8.41M Buy
65,495
+4,048
+7% +$499K 0.29% 90
2020
Q4 		$7.32M Buy
61,447
+3,156
+5% +$385K 0.26% 100
2020
Q3 		$6.67M Sell
58,291
-64,310
-52% -$7.6M 0.28% 99
2020
Q2 		$14M Buy
122,601
+21,721
+22% +$2.3M 0.47% 54
2020
Q1 		$8.1M Buy
100,880
+90,734
+894% +$9.39M 0.37% 61
2019
Q4 		$1.08M Sell
10,146
-5,299
-34% -$553K 0.04% 354
2019
Q3 		$1.65M Sell
15,445
-1,059
-6% -$109K 0.07% 284
2019
Q2 		$1.68M Buy
16,504
+88
+0.5% +$8.46K 0.06% 305
2019
Q1 		$1.48M Sell
16,416
-13,824
-46% -$1.2M 0.06% 285
2018
Q4 		$2.52M Sell
30,240
-13,195
-30% -$1.24M 0.12% 194
2018
Q3 		$4.68M Sell
43,435
-21,232
-33% -$2.33M 0.18% 141
2018
Q2 		$7.11M Sell
64,667
-19,644
-23% -$2.05M 0.25% 105
2018
Q1 		$8.45M Buy
84,311
+8,682
+11% +$889K 0.29% 92
2017
Q4 		$7.45M Buy
75,629
+20,039
+36% +$1.9M 0.25% 103
2017
Q3 		$5.2M Buy
55,590
+2,310
+4% +$245K 0.3% 86
2017
Q2 		$5.92M Buy
53,280
+138
+0.3% +$14.6K 0.36% 66
2017
Q1 		$5.22M Buy
+53,142
New +$5.07M 0.24% 107

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Achmea Investment Management's DGX Position: Q2 2026 in Review

Achmea Investment Management reduced its Quest Diagnostics (DGX) stake by 9% in Q2 2026, selling an estimated $2.42M and leaving 124,786 shares worth $26.4M. The position accounts for 0.66% of the portfolio, ranked #43.

Achmea Investment Management first reported a position in DGX in Q1 2017 and has held it in 37 quarters since. The position peaked at $27.5M in Q3 2025. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Achmea Investment Management held 124,786 shares of Quest Diagnostics worth $26.4M as of Q2 2026.
  • Achmea Investment Management sold 12,333 Quest Diagnostics shares in Q2 2026, an estimated $2.42M.
  • Quest Diagnostics made up 0.66% of Achmea Investment Management's portfolio in Q2 2026, its #43 holding.
  • Achmea Investment Management first reported a position in Quest Diagnostics in Q1 2017 and has held it in 37 quarters since.
  • Achmea Investment Management's Quest Diagnostics position peaked at $27.5M in Q3 2025.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Achmea Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.